Table of Contents   This Chapter   All Chapters

FURTHER READING

Bachot N, Roujeau J-C. Differential diagnosis of severe drug eruptions. Am J Clin Dermatol 2003; 4: 561–72

Bigby M, Jick S, Jick H et al. Drug-induced cutaneous reactions: a report from the Boston collaborative drug surveillance program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 1986; 256: 3358–63

Bork K. Cutaneous Side-effects of Drugs. Philadelphia: Saunders, 1988

Breathnach SM, Hintner H. Adverse Drug Reactions and the Skin. Oxford: Blackwell Scienti?c Publications, 1992

Dereure O et al. Drug-induced skin pigmentation. Epidemiology, diagnosis and treatment. Am J Clin Dermatol 2001; 2: 253–62

Halevy S, Shai A. Lichenoid drug eruptions. J Am Acad Dermatol 1993; 29: 249–55

Mahboob A, Haroon TS. Drugs causing ?xed eruptions: a study of 450 cases. Int J Dermatol 1998; 37: 833–8

Roujeau J-C, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272–85

Roujeau J-C et al. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 1991; 127: 1333–8

Susser WS et al. Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol 1999; 40: 376–98

Wolff K, Tappenheimer G. Treatment of toxic epidermal necrolysis: the uncertainty persists but the fog is dispersing. Arch Dermatol 2001; 139: 85–6

Wolverton SE. Update on cutaneous drug eruptions. Adv Dermatol 1997; 13: 65–83

White/Cox: Diseases of the Skin, 2ed.(c) 2006, Elsevier Inc. All rights reserved.